Page 155 - Genentech News Today

FinancialContent fully hosted finance channel

/PRNewswire/ -- At the 2023 ASCO annual meeting, investigators from OneOncologys clinical team will present Oral Abstracts using real-world data to evidence...

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, has been invited to the White House to...

Local landscape photographers Binh Danh and Chris McCaw reframe the work by the American icon in new de Young Museum exhibition.

Treatment with Ocrevus reduced B-cells receptors' diversity, but not that of T-cells' receptors, in relapsing MS patients.

While inflation continues to fall, coming in at 4.9% in April, the lowest figure since June 2022's peak of 9.1%, American workers are still feeling the pinch....

The addition of the immune checkpoint inhibitor to the current standard of care in the first-line setting improved overall survival by 40%.

The recent success of chimeric antigen receptor-T cell therapy, along with three high-profile FDA approvals, may help make precision medicine a reality in lupus, according to a presenter at the Biologic Therapies Summit.“It is prime time for biologic therapies and the treatment of lupus,” Emily Littlejohn, DO, MPH, of the department of rheumatologic and immunologic disease at the

Operator: Good day, everyone and welcome to Affimeds First Quarter 2023 Earnings and Corporate Update Call. At this time, all participants are in a listen-only mode.

/PRNewswire/ -- ProductLife Group (PLG), the global and specialized provider of regulatory, vigilance and quality services for the Pharmaceutical, Biotech and...